Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: Do androgens play a role?

Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria

(2008) Robert P. Kauffman et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

TheDGAT2gene is a candidate for the dissociation between fatty liver and insulin resistance in humans

(2008) Konstantinos Kantartzis et al.   CLINICAL SCIENCE

Current treatment of non-alcoholic fatty liver disease

(2008) Mohamed H. Ahmed et al.   DIABETES OBESITY & METABOLISM

Causes and Metabolic Consequences of Fatty Liver

(2008) Norbert Stefan et al.   ENDOCRINE REVIEWS

Diagnosis and Therapy of Nonalcoholic Steatohepatitis

(2008) Dawn M. Torres et al.   GASTROENTEROLOGY

Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease

(2008) Wolfram Goessling et al.   GASTROENTEROLOGY

The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome

(2008) D. Preiss et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Liver and heart: A new link?

(2008) Stefano Bellentani et al.   JOURNAL OF HEPATOLOGY

Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation

(2008) Tomoko Asagami et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Diagnosis of Nonalcoholic Fatty Liver Disease: Invasive versus Noninvasive

(2008) Anna Wieckowska et al.   SEMINARS IN LIVER DISEASE

Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease

(2008) Janice Jou et al.   SEMINARS IN LIVER DISEASE